Covered recipient · General Payments record
YOLANDA C BRADY
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$1,788.46
- Reported across 73 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $372.60 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $199.04 | 8 |
| Lilly USA, LLC | $45.08 | 3 |
| Astellas Pharma US Inc | $41.29 | 2 |
| Exact Sciences Corporation | $31.38 | 2 |
| ABBVIE INC. | $20.85 | 1 |
| Abbott Laboratories | $20.22 | 1 |
| PFIZER INC. | $14.74 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $20.22 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125370247 | CMS |
| ABBVIE INC. | $20.85 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103360913 | CMS |
| Astellas Pharma US Inc | $21.25 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139324334 | CMS |
| Astellas Pharma US Inc | $20.04 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139268366 | CMS |
| Exact Sciences Corporation | $15.69 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114597965 | CMS |
| Exact Sciences Corporation | $15.69 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114597969 | CMS |
| Lilly USA, LLC | $13.67 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135487870 | CMS |
| Lilly USA, LLC | $15.42 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135505204 | CMS |
| Lilly USA, LLC | $15.99 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135487872 | CMS |
| Novo Nordisk Inc | $16.00 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097279078 | CMS |
| Novo Nordisk Inc | $14.20 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097465093 | CMS |
| Novo Nordisk Inc | $17.42 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097809629 | CMS |
| Novo Nordisk Inc | $19.15 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096829047 | CMS |
| Novo Nordisk Inc | $15.03 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096979695 | CMS |
| Novo Nordisk Inc | $14.23 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096922438 | CMS |
| Novo Nordisk Inc | $87.40 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097721018 | CMS |
| Novo Nordisk Inc | $15.61 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097645099 | CMS |
| PFIZER INC. | $14.74 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130933871 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.